腹腔镜与开腹肝切除治疗大肝癌的倾向性评分匹配对比分析
本研究基于前瞻性维护数据库纳入215例大肝癌(直径≥5 cm)肝切除患者,比较腹腔镜组(n=109)与开腹组(n=106)的围术期结局和生存,经1:1倾向性评分匹配后每组70例。匹配后腹腔镜组住院时间更短(7 vs 9.5天,p=0.001),R0切除率、并发症率、总生存和无复发生存两组相似。多因素分析显示大范围切除和大量失血是手术并发症的独立预测因素,R1切除、多灶性HCC和微血管侵犯是次优无复发生存的独立预测因素,腹腔镜手术与手术并发症和次优无复发生存无关。
要点
- 大肝癌腹腔镜肝切除组住院时间短于开腹组(7 vs 9.5天,p=0.001)。
- 匹配后两组R0切除率、并发症率、总生存和无复发生存相似。
- 腹腔镜手术与手术并发症及次优无复发生存无关。
核心结论
- 在选定的大肝癌患者中,腹腔镜肝切除改善围术期结局且长期生存不劣于开腹肝切除。
研究设计与样本
- 基于前瞻性维护数据库的倾向性评分匹配对比分析,纳入215例大肝癌(直径≥5 cm)肝切除,腹腔镜组109例、开腹组106例,1:1匹配后每组70例。
主要发现
- 匹配后腹腔镜组住院时间短于开腹组(7 vs 9.5天,p=0.001)。
- 匹配后两组R0切除率、并发症率、总生存和无复发生存相似。
- 多因素分析显示大范围切除(p<0.001)和大量失血(p=0.042)是手术并发症的独立预测因素。
- 多因素分析显示R1切除(p=0.011)、多灶性HCC(p=0.005)和微血管侵犯(p=0.001)是次优无复发生存的独立预测因素。
- 腹腔镜手术与手术并发症和次优无复发生存无关。
临床怎么用
- 对于经选择的大肝癌患者,腹腔镜肝切除可作为开腹肝切除的替代选择,有助于缩短住院时间。
- 应关注大范围切除和大量失血以降低手术并发症风险。
- R1切除、多灶性HCC和微血管侵犯提示次优无复发生存风险较高。
局限性
- 单中心回顾性分析,样本量有限,结论需多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the benefits of laparoscopic hepatectomy (LH) for hepatocellular carcinoma (HCC) in most circumstances are evident, the benefits for large HCC are contentious. This study aimed to compare the perioperative outcomes and survival after LH versus open hepatectomy (OH) in large HCC patients. METHODS: An analysis of prospectively maintained database included 215 hepatectomies for large HCC (diameter ≥ 5 cm). The operative and survival outcomes were compared between the LH group (n = 109) and the OH group (n = 106). Propensity score matching (PSM) 1:1 included 70 patients in each group. The entire cohort multivariable analyses were performed to identify the factors associated with surgical complications and suboptimal recurrence-free survival (RFS). RESULTS: After PSM, baseline characteristics and the extent of liver resection were similar in both groups. The LH group had a shorter hospital stay than the OH group (7 vs 9.5 days, p = 0.001). The R0 resection rate, complication rate, overall survival, and RFS were similar between the groups. The multivariate analyses revealed two independent factors predicting surgical complication (major resection; p < 0.001 and large volume blood loss; p = 0.042), and 3 independent factors predicting suboptimal RFS including R1 resection (p = 0.011), multifocal HCC (p = 0.005), and microvascular invasion (p = 0.001). LH was not associated with surgical complication and suboptimal RFS. CONCLUSION: Our study highlights the benefits of LH by improving the perioperative outcomes, without long-term survival inferiority in selected large HCC patients compared with conventional OH. LH can be an attractive option for large HCC treatment.
引用
- Dumronggittigule W, Han HS, Komoltri C, et al. Laparoscopic versus open hepatectomy for large hepatocellular carcinoma: a single center propensity-score-matching comparative analysis of perioperative outcomes and long-term survival. Surg Endosc. 2022. PMID: 36520225. doi:10.1007/s00464-022-09812-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。